In a piece for investing blog Seeking Alpha, contributor Sarah Maller discusses her reasons for giving up on health care giant Johnson & Johnson as a viable investment.
“Manufacturing problems and recalls are not just embarrassing,” she writes, “but they are a worrisome sign that management has taken its eye off the ball in many key respects.”
Maller specifically mentions a recall that Johnson & Johnson initiated for its LPS Diaphyseal Sleeve, ...
continue reading...
The Indian company Ranbaxy will resume production of its generic version of the anti-cholesterol drug Lipitor in the United States, according to a Reuters story.
The company had recalled the drug, called atorvastatin, in November after particles of glass were found in certain lots.
The original Lipitor, manufactured by Pfizer Inc., has also been the source of some safety concerns.
The U.S. Food and Drug Administration has added warnings to the labels of ...
continue reading...
In the course of a recently concluded trial over a medical imaging dye called Omniscan, witnesses claimed that manufacturer GE Healthcare actively tried to suppress evidence that the dye could be dangerous, ProPublica reports.
A jury in Cleveland recently awarded $4.5 million to the plaintiff – a 61-year-old man diagnosed with a disease called nephrogenic systemic fibrosis in 2010 — and $500,000 to his wife. Prior to that trial, GE had ...
continue reading...
A new study by Canadian researchers found that strong doses of the anti-cholesterol drugs called statins put patients at risk of potentially deadly kidney problems, The Daily Telegraph reports.
The researchers, from the Lady Davis Institute for Medical Research in Quebec, said that taking high doses of atorvastatin — better known by its brand name Lipitor — simvastatin or rosuvastatin increases the risk of being hospitalized with a condition called acute ...
continue reading...
A study linked the cholesterol drug Tredaptive to serious side effects that included development of diabetes, gastrointestinal problems, bleeding and infections, according to a Reuters report.
Manufacturer Merck had already decided not to sell the drug in the United States and to take it off the market in dozens of other countries, after findings that it failed to prevent heart attacks, strokes, death and other complications in heart patients.
Tredaptive isn’t ...
continue reading...
A Massachusetts drug compounder called Pallimed Solutions has voluntarily recalled more than a dozen sterile drugs and compounds following an inspection, CNN reports.
Although the company says it has no indication that any if its products are unsafe or contaminated, it did not reveal what the inspection found that prompted the recall.
Compounding pharmacies prepare specialty variations on prescriptions for individual patients in response to physician orders. They aren’t subject to ...
continue reading...
